49 related articles for article (PubMed ID: 23975733)
1. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
[TBL] [Abstract][Full Text] [Related]
3. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
4. SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway.
Lan R; Yu Y; Song J; Xue M; Gong H
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38426532
[TBL] [Abstract][Full Text] [Related]
5. Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions.
Zhao J; He Q; Gong Z; Chen S; Cui L
Springerplus; 2016; 5(1):1436. PubMed ID: 27652012
[TBL] [Abstract][Full Text] [Related]
6. Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population.
Bingen JM; Clark LV; Band MR; Munzir I; Carrithers MD
Front Genet; 2022; 13():1058817. PubMed ID: 36685876
[TBL] [Abstract][Full Text] [Related]
7. Coexpression Network Analysis of lncRNA Associated with Overexpression of DNMT1 in Esophageal Epithelial Cells.
Lei Y; Xu Y; Li XF; Chen Y
Biomed Res Int; 2021; 2021():7162270. PubMed ID: 34660799
[TBL] [Abstract][Full Text] [Related]
8. The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.
Angulo JC; Manini C; López JI; Pueyo A; Colás B; Ropero S
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922974
[TBL] [Abstract][Full Text] [Related]
9. The emerging spectrum of early life exposure-related inflammation and epigenetic therapy.
Yang Q; Ali M; El Andaloussi A; Al-Hendy A
Cancer Stud Mol Med; 2018 Nov; 4(1):13-23. PubMed ID: 30474062
[TBL] [Abstract][Full Text] [Related]
10. [Effects of downregulated N-cadherin expression on THP-1 cell line and its mechanism].
Ma J; Liu YJ; Liu XY; Tang P; Ma P; Yu QF; Zhang ZF; Li N; Gan SL; Sun H
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):514-517. PubMed ID: 30032572
[No Abstract] [Full Text] [Related]
11. Targeting DNA Methyltranferases in Urological Tumors.
Marques-Magalhães Â; Graça I; Henrique R; Jerónimo C
Front Pharmacol; 2018; 9():366. PubMed ID: 29706891
[TBL] [Abstract][Full Text] [Related]
12. miR-502-mediated histone methyltransferase
Zhang S; Guo Z; Xu J; Wang J; Zhang J; Cui L; Zhang H; Liu Y; Bai Y
Oncol Lett; 2017 Dec; 14(6):7131-7138. PubMed ID: 29250163
[TBL] [Abstract][Full Text] [Related]
13. Wnt Signaling in Renal Cell Carcinoma.
Xu Q; Krause M; Samoylenko A; Vainio S
Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27322325
[TBL] [Abstract][Full Text] [Related]
14. The role of epigenetics in kidney malignancies.
la Rosa AH; Acker M; Swain S; Manoharan M
Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells.
Konac E; Varol N; Kiliccioglu I; Bilen CY
Oncol Lett; 2015 Jul; 10(1):560-564. PubMed ID: 26171069
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Int J Clin Exp Pathol; 2014; 7(11):7597-609. PubMed ID: 25550796
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPKα-mediated reduction of DNA methyltransferase 1.
Yie Y; Zhao S; Tang Q; Zheng F; Wu J; Yang L; Deng S; Hann SS
Mol Cell Biochem; 2015 Apr; 402(1-2):63-74. PubMed ID: 25547067
[TBL] [Abstract][Full Text] [Related]
18. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
19. Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.
Torres-Martin M; Lassaletta L; Isla A; De Campos JM; Pinto GR; Burbano RR; Castresana JS; Melendez B; Rey JA
Oncol Rep; 2014 Dec; 32(6):2327-34. PubMed ID: 25333347
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Chin J Cancer Res; 2014 Aug; 26(4):371-81. PubMed ID: 25232208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
